Elevated levels of TGF-β1 are associated with lymph node metastasis [58] and promote targeted migration through the lymphatic system in animal breast tumor models [59,60], while TGF-β blockade inhibits mammary tumor growth and metastasis and improves chemotherapy efficacy [61]. Here, TGFB1 is linked to breast cancer.